Science Explorer Interactive view Map
Company · Tokyo · ??

AbbVie (Japan)

abbvie.co.jpROR OpenAlex
Research works
81
▲ 82% vs 2013–17
Citations
813
10.1 per fractional work
Top-10% rate
6.6%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: AbbVie (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.95× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.93× its world share, 2 worksImmunology and Micro…Neuroscience: 3.06× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.61× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.32× its world share, 0 worksChemistryComputer Science: 0.18× its world share, 0 worksComputer ScienceEnergy: 0.52× its world share, 0 worksEnergyEngineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMathematics: 0.90× its world share, 0 worksMathematicsDentistry: 0.33× its world share, 0 worksDentistryHealth Professions: 0.67× its world share, 1 worksHealth ProfessionsMedicine: 3.58× its world share, 24 worksMedicineNursing: 2.44× its world share, 0 worksNursingVeterinary: 4.92× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.32× its world share, 1 worksEconomics, Econometr…Psychology: 0.57× its world share, 1 worksPsychologySocial Sciences: 0.16× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.

Which keywords describe research at AbbVie (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurological Disorders, Headache Disorders, Migraine, Treatment, Epidemiology, Quality of Life, Parkinson's Disease and Pain Management.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Neurological Disorders9▲ 45×8 topics
  2. Headache Disorders6▲ 682×1 topic
  3. Migraine6▲ 399×1 topic
  4. Epidemiology4▲ 2.9×28 topics
  5. Treatment3▲ 7.3×11 topics
  6. Quality of Life3▲ 5.7×14 topics
  7. Inflammation2▲ 2.6×9 topics
  8. Parkinson's Disease2▲ 22×5 topics
  9. Oxidative Stress2▲ 3.1×6 topics
  10. Genetics2▲ 7.1×7 topics
  11. Pain Management2▲ 21×3 topics
  12. Stroke2▲ 25×2 topics
  13. Botulinum Toxin2▲ 71×1 topic
  14. Diagnostic Criteria2▲ 19×4 topics
  15. Neurotoxins2▲ 114×1 topic
  16. Mitochondrial Dysfunction1▲ 13×3 topics
  17. Neurobiology1▲ 15×5 topics
  18. Epilepsy1▲ 31×2 topics
  19. Neurodegeneration1▲ 11×2 topics
  20. Dopaminergic Neurons1▲ 47×1 topic
  21. a-Synuclein1▲ 58×1 topic

Which research topics does AbbVie (Japan) publish most on?

By volume in 2022–2025: Migraine and Headache Studies, Botulinum Toxin and Related Neurological Disorders, Parkinson's Disease Mechanisms and Treatments and Olfactory and Sensory Function Studies.

Migraine and Headache St…6Migraine and Headache Studies: 6 fractional worksBotulinum Toxin and Related Neurological Disorders: 2 fractional worksParkinson's Disease Mechanisms and Treatments: 1 fractional worksOlfactory and Sensory Function Studies: 1 fractional worksNeurological disorders and treatments: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksRNA regulation and disease: 1 fractional worksOphthalmology and Eye Disorders: 1 fractional worksDermatology and Skin Diseases: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional works
Psychiatry and Mental healthNeurologySensory SystemsImmunology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 6 works
  2. 2 Botulinum Toxin and Related Neurological Disorders Neurology 2 works
  3. 3 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  4. 4 Olfactory and Sensory Function Studies Sensory Systems 1 works
  5. 5 Neurological disorders and treatments Neurology 1 works
  6. 6 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  7. 7 RNA regulation and disease Molecular Biology 1 works
  8. 8 Ophthalmology and Eye Disorders Pathology and Forensic Medicine 1 works
  9. 9 Dermatology and Skin Diseases Dermatology 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.4%not open50.6%

World: 28% of research is openly available.

with international co-authors43.1%domestic only56.9%

World: 19% is written across borders.

How has AbbVie (Japan)'s research output changed?

Output in 2018–2022 was 82% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.